Preclinical Intervention: In Vivo (Animals): Drugs, Nutritional Interventions, Mechanisms

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 91-100 of 178 total displayed.

Past content

Cancer Therapy: Preclinical
Prevention and Treatment of Experimental Estrogen Receptor–Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268

Karen Liby, Renee Risingsong, Darlene B. Royce, Charlotte R. Williams, Mark M. Yore, Tadashi Honda, Gordon W. Gribble, William W. Lamph, Nicola Vannini, Ilaria Sogno, Adriana Albini, and Michael B. Sporn
Clin. Cancer Res. 2008; 14: 4556-4563. [Abstract] [Full text] [PDF]  

Prevention
Myricetin Suppresses UVB-Induced Skin Cancer by Targeting Fyn

Sung Keun Jung, Ki Won Lee, Sanguine Byun, Nam Joo Kang, Sung Hwan Lim, Yong-Seok Heo, Ann M. Bode, G. Tim Bowden, Hyong Joo Lee, and Zigang Dong
Cancer Res. 2008; 68: 6021-6029. [Abstract] [Full text] [PDF]  

Research Articles
Chemopreventive Doses of Methylselenocysteine Alter Circadian Rhythm in Rat Mammary Tissue

Xun Zhang and Helmut Zarbl
Cancer Prevention Research 2008; 1: 119-127. [Abstract] [Full text] [PDF]  

Prevention
Dietary Energy Restriction Modulates the Activity of AMP-Activated Protein Kinase, Akt, and Mammalian Target of Rapamycin in Mammary Carcinomas, Mammary Gland, and Liver

Weiqin Jiang, Zongjian Zhu, and Henry J. Thompson
Cancer Res. 2008; 68: 5492-5499. [Abstract] [Full text] [PDF]  

Prevention
Inhibition of Photocarcinogenesis by Platelet-Activating Factor or Serotonin Receptor Antagonists

Coimbatore S. Sreevidya, Noor M. Khaskhely, Atsushi Fukunaga, Polina Khaskina, and Stephen E. Ullrich
Cancer Res. 2008; 68: 3978-3984. [Abstract] [Full text] [PDF]  

Prevention
Reduced Colitis-Associated Colon Cancer in Fat-1 (n-3 Fatty Acid Desaturase) Transgenic Mice

Qian Jia, Joanne R. Lupton, Roger Smith, Brad R. Weeks, Evelyn Callaway, Laurie A. Davidson, Wooki Kim, Yang-Yi Fan, Peiying Yang, Robert A. Newman, Jing X. Kang, David N. McMurray, and Robert S. Chapkin
Cancer Res. 2008; 68: 3985-3991. [Abstract] [Full text] [PDF]  

Prevention
OSU-HDAC42, a Histone Deacetylase Inhibitor, Blocks Prostate Tumor Progression in the Transgenic Adenocarcinoma of the Mouse Prostate Model

Aaron M. Sargeant, Robert C. Rengel, Samuel K. Kulp, Russell D. Klein, Steven K. Clinton, Yu-Chieh Wang, and Ching-Shih Chen
Cancer Res. 2008; 68: 3999-4009. [Abstract] [Full text] [PDF]  

Research Articles: Therapeutics, Targets, and Development
The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis

Karen Liby, Candice C. Black, Darlene B. Royce, Charlotte R. Williams, Renee Risingsong, Mark M. Yore, Xi Liu, Tadashi Honda, Gordon W. Gribble, William W. Lamph, Thomas A. Sporn, Ethan Dmitrovsky, and Michael B. Sporn
Mol. Cancer Ther. 2008; 7: 1251-1257. [Abstract] [Full text] [PDF]  

Research Articles: Therapeutics, Targets, and Development
Human papillomavirus type 16 L1E7 chimeric capsomeres have prophylactic and therapeutic efficacy against papillomavirus in mice

Tao Bian, Yue Wang, Zhenhua Lu, Zhenmei Ye, Li Zhao, Jiao Ren, Hui Zhang, Li Ruan, and Houwen Tian
Mol. Cancer Ther. 2008; 7: 1329-1335. [Abstract] [Full text] [PDF]  

Prevention
Helicobacter pylori Eradication Prevents Progression of Gastric Cancer in Hypergastrinemic INS-GAS Mice

Chung-Wei Lee, Barry Rickman, Arlin B. Rogers, Zhongming Ge, Timothy C. Wang, and James G. Fox
Cancer Res. 2008; 68: 3540-3548. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18